Intrauterine Balloon Tamponade Improves Hemorrhage Control

Postpartum outcomes were assessed based on discharge abstract data from the French national medical information system.

The results revealed that invasive procedures were assumed in 298 women, representing 4.1 per 1,000 deliveries. The cohort network had a significantly lower proportion of women with at least one invasive procedure (3/1,000), compared to the control network (5.1/1,000). The study perinatal network also had significantly lower use of arterial embolization for those who delivered vaginally. Risk of an invasive procedure remained significantly lower in the cohort network for women who delivered vaginally, but not for women who delivered by Cesarean section. The study was published on December 4, 2017, in Obstetrics & Gynecology.

“The use of intrauterine balloon tamponade in routine clinical practice is associated with a significantly lower use of invasive procedures among women undergoing vaginal delivery,” concluded lead author Mathilde Revert, MSc, and colleagues. “After controlling for potential confounding factors, the risk of an invasive procedure among women who delivered vaginally remained significantly lower in the pilot network, but not for women who delivered by Cesarean.”

Postpartum hemorrhage is the leading direct cause of maternal death worldwide. Intrauterine balloon tamponade is a minimally invasive intervention that involves inserting a balloon device into the uterus and then incrementally filling it with liquid, which applies pressure to the uterus until the bleeding stops. Even when it cannot completely control severe postpartum hemorrhage, it can still serve a critical role by reducing blood loss until the woman can be transported to a facility with surgical management and other treatment options.

Related Links:
Université de Versailles Saint-Quentin-en-Yvelines